investors

Mylan, embattled maker of EpiPen, faces a crucial test as angry investors plot to oust CEO
Mylan, embattled maker of EpiPen, faces a crucial test as angry investors plot to oust CEO
Stat
Mylan Labs
EpiPens
investors
Heather Bresch
Flag link:
Investors are being told to go scorched earth on the company that makes EpiPen
Investors are being told to go scorched earth on the company that makes EpiPen
Yahoo/Business Insider
Mylan Labs
investors
EpiPens
Flag link:
Pfizer investors slam new price increases as 'out of step’ with its Big Pharma rivals
Pfizer investors slam new price increases as 'out of step’ with its Big Pharma rivals
Fierce Pharma
Pfizer
investors
drug pricing
Flag link:
What Valeant Pharmaceuticals' Latest Sale Means (and Doesn't Mean) for Investors
What Valeant Pharmaceuticals' Latest Sale Means (and Doesn't Mean) for Investors
Motley Fool
Valeant Pharmaceuticals
investors
M&A
iNova
Flag link:
An anonymous blogger angers biotech investors. But are his posts illegal?
An anonymous blogger angers biotech investors. But are his posts illegal?
Bizjournals.com
bloggers
investors
biotech
Mako Research
Flag link:
U.S. medtech shares gain as investors seek shelter from drug price debate
U.S. medtech shares gain as investors seek shelter from drug price debate
Yahoo/Reuters
devices
investors
drug pricing
Flag link:
5 biotech CEOs on payers, investors and big bets
5 biotech CEOs on payers, investors and big bets
BioPharma Dive
biotech
payers
investors
Gil Van Bokkelen
Athersys
Robert McNeil
DalCor Pharmaceuticals
Pierre Belichard
Enterome
Michael Metzger
Syndax
Spiro Rombotis
Cyclacel
Flag link:
Drugmakers fall as investors see pricing threat from Trump
Drugmakers fall as investors see pricing threat from Trump
Yahoo/AP
investors
pharma stocks
drug pricing
Donald Trump
Flag link:
Investors in big pharma, biotech look to ride out Trump storm
Investors in big pharma, biotech look to ride out Trump storm
Yahoo/Reuters
Donald Trump
investors
Flag link:
What Biotech Investors Can Expect From the J.P. Morgan Healthcare Conference 2017
What Biotech Investors Can Expect From the J.P. Morgan Healthcare Conference 2017
TheStreet.com
biotech
investors
JPMHC 2017
JPMorgan
Flag link:
Hedge Fund Investor Sues Theranos For Lying 'Knowingly And Repeatedly'
Hedge Fund Investor Sues Theranos For Lying 'Knowingly And Repeatedly'
Forbes
Theranos
investors
hedge funds
diagnostics
Flag link:
Did Pfizer's No-Split Decision Cost Investors a Lot of Money?
Did Pfizer's No-Split Decision Cost Investors a Lot of Money?
Investopedia
Pfizer
investors
Flag link:
Witty wins praise for GSK's social conscience as investors call for new leadership
Witty wins praise for GSK's social conscience as investors call for new leadership
Fierce Pharma
Andrew Witty
Pharma CEOs
GSK
investors
Flag link:
Sanofi hits up Medivation investors with 34 pages of fault-finding and promises
Sanofi hits up Medivation investors with 34 pages of fault-finding and promises
Fierce Pharma
Sanofi
Medivation
investors
M&A
hostile takeover
Flag link:
Pfizer investors stand with CEO Read even though he is 0 for 2 on megamergers
Pfizer investors stand with CEO Read even though he is 0 for 2 on megamergers
Fierce Pharma
Pfizer
investors
Pharma CEOs
Ian Read
Allergan
M&A
Flag link:
Aveo to pay $4m to settle investor fraud charges
Aveo to pay $4m to settle investor fraud charges
Stat
Aveo Pharmaceuticals
tivozanib
kidney cancer
investors
Flag link:
Only a 'mad' GlaxoSmithKline won't follow my advice, Woodford says
Only a 'mad' GlaxoSmithKline won't follow my advice, Woodford says
Fierce Pharma
GSK
investors
reorganization
Flag link:
Allergan investors still too 'skeptical' about a Pfizer merger, analyst says
Allergan investors still too 'skeptical' about a Pfizer merger, analyst says
Fierce Pharma
Allergan
investors
Pfizer
M&A
Flag link:
Shire PLC, Baxalta Inc: Investors’ Reactions To Higher Bid Reports
Shire PLC, Baxalta Inc: Investors’ Reactions To Higher Bid Reports
Bidness, ETC
Shire
Baxalta
investors
M&A
Flag link:
Aegerion's CEO resigns after standoff with activist investors
Aegerion's CEO resigns after standoff with activist investors
Fierce Biotech
Aegerion Pharmaceuticals
investors
Flag link: